Quality of life in patients with CRB1-associated retinal dystrophies: A longitudinal study

被引:5
作者
Karuntu, Jessica S. [1 ]
Nguyen, Xuan-Thanh-An [1 ]
Talib, Mays [1 ]
van Schooneveld, Mary J. [2 ]
Wijnholds, Jan [1 ,3 ]
van Genderen, Maria M. [4 ,5 ]
Schalij-Delfos, Nicoline E. [1 ]
Klaver, Caroline C. W. [6 ,7 ,8 ,9 ]
Meester-Smoor, Magda A. [6 ]
van den Born, L. Ingeborgh [11 ]
Hoyng, Carel B. [8 ]
Thiadens, Alberta A. H. J. [6 ]
Bergen, Arthur A. [10 ]
van Nispen, Ruth M. A. [12 ]
Boon, Camiel J. F. [1 ,2 ,13 ]
机构
[1] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[2] Amsterdam UMC, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[3] Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands
[4] Bartimeus, Diagnost Ctr complex visual disorders, Zeist, Netherlands
[5] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[6] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands
[7] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[8] Radboud Univ Nijmegen, Dept Ophthalmol, Med Ctr, Nijmegen, Netherlands
[9] Inst Mol & Clin Ophthalmol, Basel, Switzerland
[10] Amsterdam UMC, Dept Clin Genet, Acad Med Ctr, Amsterdam, Netherlands
[11] Rotterdam Eye Hosp, Rotterdam, Netherlands
[12] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Ophthalmol, Amsterdam UMC, Amsterdam, Netherlands
[13] Univ Amsterdam, Dept Ophthalmol, Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
关键词
CRB1; inherited retinal dystrophy; National Eye Institute Visual Function Questionnaire; patient-reported outcome measure; quality of life; REPORTED OUTCOMES; NEI VFQ-25;
D O I
10.1111/aos.15769
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess the longitudinal vision-related quality of life among patients with CRB1-associated inherited retinal dystrophies. Methods: A longitudinal questionnaire study included 22 patients with pathogenic CRB1 variants. The National Eye Institute Visual Function Questionnaire (39 items, NEI VFQ-39) was applied at baseline, two-year follow-up, and 4-year follow-up. Classical test theory was performed to obtain subdomain scores and in particular 'near activities' and 'total composite' scores. The Rasch analysis based on previous calibrations of the NEI VFQ-25 was applied to create visual functioning and socio-emotional subscales. Results: In total, 22 patients with pathogenic CRB1 variants were included, with a median age of 25.0 years (IQR: 13-31 years) at baseline and mean followup of 4.0 +/- 0.3 years. A significant decline at 4 years was observed for 'near activities' (51.0 +/- 23.8 vs 35.4 +/- 14.7, p = 0.004) and 'total composite' (63.0 +/- 13.1 vs 52.0 +/- 12.1, p = 0.001) subdomain scores. For the Rasch-scaled scores, the 'visual functioning' scale significantly decreased after 4 years (- 0.89 logits; p = 0.012), but not at 4-year follow-up (+0.01 logits; p = 0.975). The 'socio- emotional' scale also showed a significant decline after 2 years (-0.78 logits, p = 0.033) and 4 years (- 0.83 logits, p = 0.021). Conclusion: In the absence of an intervention, a decline in vision-related quality of life is present in patients with pathogenic CRB1 variants at 4-year follow-up. Patient-reported outcome measures should be included in future clinical trials, as they can be a potential indicator of disease progression and treatment efficacy.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 31 条
  • [1] Evaluation of vision-related quality of life in retinitis pigmentosa patients with low vision
    Altinbay, Deniz
    Taskin, Ibrahim
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2021, 65 (06) : 777 - 785
  • [2] Assessment of Night Vision Problems in Patients with Congenital Stationary Night Blindness
    Bijveld, Mieke M. C.
    van Genderen, Maria M.
    Hoeben, Frank P.
    Katzin, Amir A.
    van Nispen, Ruth M. A.
    Riemslag, Frans C. C.
    Kappers, Astrid M. L.
    [J]. PLOS ONE, 2013, 8 (05):
  • [3] Rasch Analysis for Instrument Development: Why, When, and How?
    Boone, William J.
    [J]. CBE-Life Sciences Education, 2016, 15 (04):
  • [4] Early and late stage gene therapy interventions for inherited retinal degenerations
    Botto, Catherine
    Rucli, Marco
    Tekinsoy, Muge Defne
    Pulman, Juliette
    Sahel, Jose-Alain
    Dalkara, Deniz
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2022, 86
  • [5] Clemons TE, 2003, ARCH OPHTHALMOL-CHIC, V121, P211
  • [6] Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience
    Dimopoulos, Ioannis S.
    Hoang, Stephanie C.
    Radziwon, Alina
    Binczyk, Natalia M.
    Seabra, Miguel C.
    MacLaren, Robert E.
    Somani, Rizwan
    Tennant, Matthew T. S.
    MacDonald, Ian M.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 193 : 130 - 142
  • [7] The NEI VFQ-25C: Calibrating Items in the National Eye Institute Visual Function Questionnaire-25 to Enable Comparison of OutcomeMeasures
    Goldstein, Judith E.
    Bradley, Chris
    Gross, Alden L.
    Jackson, Marylou
    Bressler, Neil
    Massof, Robert W.
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2022, 11 (05):
  • [8] Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular Degeneration
    Khadka, Jyoti
    McAlinden, Colm
    Pesudovs, Konrad
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (03) : 1276 - 1276
  • [9] Patient-reported outcome measures in inherited retinal degeneration gene therapy trials
    Lacy, Gabrielle D.
    Abalem, Maria Fernanda
    Musch, David C.
    Jayasundera, Kanishka T.
    [J]. OPHTHALMIC GENETICS, 2020, 41 (01) : 1 - 6
  • [10] Physical Activity and Quality of Life in Retinitis Pigmentosa
    Levinson, Joshua D.
    Joseph, Ethan
    Ward, Laura A.
    Nocera, Joe R.
    Pardue, Machelle T.
    Bruce, Beau B.
    Yan, Jiong
    [J]. JOURNAL OF OPHTHALMOLOGY, 2017, 2017